Abstract Although microvascular decompression (MVD) is a reliable treatment for hemifacial spasm (HFS), the postoperative course is varied. We retrospectively analyzed the resolution pattern of the spasm and specified predictors for delayed cure after MVD. This study included 114 consecutive patients with typical HFS. All of them were followed up for at least 1 year after operation. Patients were divided into three groups depending on the postoperative course: immediate cure, delayed cure, and failure. To identify the predictive factors for delayed cure after MVD, logistic regression analyses were applied using candidate clinical factors, such as duration of symptom, the tendency of the spasm, preoperative medical treatment, and offending vessels. Among the 114 patients, 107 patients were cured. For those cured, 65 patients were classified as immediate cure and 42 patients were classified as delayed cure. Cumulative spasm-free rates after 1 week, 1 month, and 3 months after MVD were 70, 88, and 97 %, respectively. No predictive factors between the cured and failure groups were observed. According to multivariate analysis, preoperative anticonvulsant therapy was found to be the sole significant predictive factor for delayed cure after MVD (p = 0.025). A significant correlation between delayed cure and preoperative anticonvulsant therapy was found in our study, which suggests that hyperexcitation of the facial nucleus plays an important role in pathogenesis of delayed cure. Therefore, if a patient demonstrating a positive response to preoperative anticonvulsant therapy showed a persistent spasm after MVD, reoperation should be delayed for at least 3 months after the initial operation.
Introduction
Hemifacial spasm (HFS) is unilateral twitching, tonic spasms, and synkinesis of the mimetic muscles innervated by the seventh cranial nerve. HFS is not life threatening, but it is an annoying disease for patients by limiting normal daily activities. Medical treatment (like anticonvulsants or GABAergic drugs) is generally ineffective and local botulinum neurotoxin A injections commonly wear off in 3-4 months. Microvascular decompression (MVD) of the facial nerve has been well known as an effective and reliable treatment for HFS, which can achieve marked improvements in the majority of patients, with a cure rate of around 90 % [5, 7, 8, 12] . Interestingly, the postoperative course of MVD is variable even though the same surgical procedure is applied. Although the majority of patients become spasm free immediately, others require a longer period of time after MVD surgery to become spasm free. In rare instances, complete resolution of HFS takes over a year. Thus, the time when to conclude if the treatment has failed or not remains unclear.
With regard to reoperation for HFS, Park et al. reported surgical outcome of the second MVD was comparable to that of the primary MVD, with an acceptable rate of adverse effects, particularly for the patients who had no benefit with the first MVD [16] . In contrast, Barker et al. reported the second MVD brought higher risks, such as failure to relieve spasm, facial palsy, and loss of hearing [1] . Thus, how to identify the right candidates for reoperation remains controversial and physicians often have difficulty determining how long to wait before reoperation in patients with persistent spasm.
The aims of this study are to analyze the resolution pattern of the spasm and specify predictors in numerous clinical parameters for delayed cure after MVD. We also propose an appropriate timing of the second MVD for patients with persistent spasm.
Methods Patients
This retrospective study was conducted with institutional review board approval from Hokkaido University (015-0028). The study included consecutive 114 patients with typical HFS who were treated at the Hokkaido University Hospital and Teine Keijinkai Medical Center using the same treatment strategies. All of them have been followed up for at least 1 year after the initial MVD.
Patients are defined as Bcured^if they had no spasm without any medication over a 1-year follow-up period. According to the duration between MVD and resolution of spasm, resolution pattern was divided into two groups: Bimmediate cureâ nd Bdelayed cure.^The immediate cure is assigned to the group with the complete abolition of spasm on the next day of the operation. The remainder is defined as delayed cure. Patients are defined as Bfailure^if they had remaining spasm based on subjective patient assessments over the 1-year follow-up period.
We retrospectively analyzed the patient's clinical data and surgical findings. The following clinical data for the 114 patients were examined: age, gender, spasm side, duration of symptom, presence of synkinesis, the tendency of the spasm, associated symptoms, preoperative medical treatment, surgical outcome, offending vessels, and any temporary and/or permanent postoperative complications. The tendency of the spasm was categorized into three groups: mild/occasional spasm, moderate/frequent spasm, and severe/continuous spasm. Preoperative medical treatment was divided into four groups: none, anticonvulsant, botulinum toxin injection, and both. Patients who took antiepileptic drugs (AEDs) for longer than 3 months were classified into an anticonvulsant group. Regardless of symptom relief, patients who ceased AEDs within 3 months because of side effect including drug eruption, fatigue, and abnormal blood test were also classified into an anticonvulsant group. Surgical findings were obtained from operative records and videos. The lateral spread response (LSR) was excluded from logistic regression analysis because of defective data. The degree of indentation of the root exit zone (REZ) was subjective and excluded for analysis.
Operative technique
The patient was placed in a lateral position, the head was fixed in a three-pin skull clamp with the neck flexed, and the cranial vertex tilted slightly down toward the floor. Before draping, intraoperative neurophysiologic monitors including the auditory brainstem response (ABR) and the LSR were prepared. Paired surface electrodes were placed 5 mm apart along the zygomatic branch of the facial nerve, and the nerve was electrically stimulated. A normal muscle response was recorded with needle electrodes inserted into the orbicularis oculi muscle, and LSRs were recorded by using needle electrodes inserted into the mentalis muscle. The stimulating current was a 0.1-ms rectangular wave adjusted to supramaximal strength (5-20 mA). The ABR was simultaneously monitored to minimize the risk of hearing loss.
A 6-cm-long curvilinear skin incision medial to the posterior margin of the mastoid body was made and the occipital bone opening laid one third rostral and two thirds caudal to the inferior nuchal line. Removal of the bone below the bottom turn of the sigmoid sinus facilitated caudal-to-rostral surgical trajectory that was the key element for adequate exposure of the REZ of the facial nerve. The dura was incised in a C shape and reflected toward the sigmoid sinus. After identifying the spinal root of the accessory nerve in the cerebellomedullary cistern, arachnoid dissection was gradually advanced rostrally using microscissors to approach the cerebellopontine angle (CPA). We noted a triangular space bordered by the glossopharyngeal nerve, the cerebellar flocculus, and the choroid plexus. Dissecting between the flocculus and the glossopharyngeal nerve with lateral retraction of the choroid plexus allowed us to better access the REZ of the facial nerve. Since the hemifacial spasm is mostly caused by vascular compression at the REZ, we tried not to manipulate the vestibulocochlear complex and the distal part of the facial nerve. Only the possibility of distal compression was explored in the initial surgery if there were no apparent conflict vessels at the REZ.
Surgical technique of decompression depends on the size and anatomical configurations of the offending vessels. In order to achieve more secure decompression, we employed several strategies as described in the following paragraph, and often combined multiple techniques. We first attempted to translocate the vessel by wrapping a Teflon tape around it, pulling it up toward the petrosal bone, and fixing the both ends of the tape on the dural surface with fibrin glue. If the method was too difficult to perform, Teflon felt was then inserted as prosthesis between the vessel and the brainstem so as to keep the vessel away from the REZ. When sufficient decompression can be achieved, LSR usually disappears or markedly diminishes. To avoid postoperative hearing loss, ABR was sequentially monitored, and if the latency of the wave V was delayed for more than 1.0 ms, the intradural procedure was temporarily stopped to wait for the recovery.
Statistical analyses
All statistical analyses were carried out using R statistical software version 3.0.3. Continuously variable data, such as age and duration of symptom, were shown with mean values and standard deviations. The mean of continuous variables was compared by Welch t test, and the distribution of categorized data was compared by Pearson's chi-squared test.
To identify the predictive factors for delayed cure after MVD, logistic regression analyses were applied using candidate clinical factors including patient's age, gender, spasm side, duration of symptom, presence of synkinesis, the tendency of the spasm, associated symptoms, preoperative medical treatment, and offending vessels. Odds ratio, with confidence intervals (CIs), was calculated for each factor, and then, multivariate analysis was performed using the factors for which the p value was below 0.10. Statistical significance was defined as a p value less than 0.05.
Results
The demographic characteristics are summarized in Table 1 . Among 114 patients, 70 were female and 44 were male, with the mean age of 55.3 years. The preoperative duration of symptoms was 51.1 months (range 3 months to 30 years). Seventyeight patients had moderate spasm tendency and high-pitch tinnitus was the most frequently associated symptom (12.4 %). Preoperative medication with AEDs was given to 47 patients (41.2 %), and the mean duration of anticonvulsant medication was 23.4 months. AEDs include carbamazepine, diazepam, clonazepam, and phenytoin. Clonazepam, a benzodiazepine drug having anxiolytic, anticonvulsant, muscle relaxant, and sedative properties, is the most common prescription drug. Patients in the group of anticonvulsant therapy showed varied degrees of symptom improvement, but no patient was spasm free. Seven patients had continued medication for 3 years or more. Eight patients underwent surgery within 1 year. The other 30 patients have taken various doses of AEDs during 1 to 3 years. Two patients who showed marked symptom relief stopped medication within 3 months due to drug eruption and liver dysfunction. Preoperative botulinum injection was performed in 18 patients (15.8 %). Although the anterior inferior cerebellar artery was the most frequent offending vessel, 24 patients (20.5 %) had multiple conflicting vessels.
In our cohort, 107 (93.9 %) patients were cured. In the cured group, 65 (60.7 %) patients were classified into the immediate cure group and those with delayed cure consisted of 42 patients (39.2 %). In the group of 42 patients with delayed cure, 26 patients were responsive to preoperative medication with AEDs (Table 2) . Cumulative spasm-free rates at 1 week, 1 month, and 3 months after operation were 70, 88, and 97 %, respectively. Seven patients with residual spasm over 1 year after operation were classified as failure. Patients in the failure group comprised three men and four women, with the mean age of 52.3 years and the mean preoperative duration of symptoms of 39 months.
The data analysis of LSR in 34 patients is shown in Table 3 . After MVD procedure, the LSR disappeared in 29 patients and persisted in 5 patients. In the LSR-disappearance group, eight patients showed residual spasm postoperatively. On the other hand, in the LSR-persistence group, three patients showed immediate cure. No statistical significance was found in categorized data by Pearson's chi-squared test (p = 0.34).
There was no significant association between surgical outcome (cure or failure) and clinical factors (Table 4) . Two failed patients showing initial improvement and subsequent aggravation of HFS after MVD had excellent results after reoperation. The surgical finding showed a compressive vessel at the distal portion of the facial nerve in one patient and Teflon felt migration in another patient. The major postoperative complications included permanent hearing loss in three patients (2.6 %), permanent facial palsy (H&B grade II) in one patient (0.9 %), and CSF leakage in two patients (1.8 %). There was neither death nor ischemic insults in our cohort.
Predictive factors for delayed cure
To identify which clinical factors influenced the delayed cure, we analyzed the cured group using the logistic regression model (Table 5 ). According to multivariate analysis, preoperative anticonvulsant therapy was found to be the sole significant predictive factor for delayed cure (p = 0.025). There was no association between the duration of preoperative anticonvulsant therapy and pattern of symptom resolution. Although the factor of multiple offending vessels was one of the possible predictive factors based on univariate analysis (p = 0.066), no association was found between it and delayed cure in multivariate analysis (p = 0.12). The duration of symptom lasting longer than 3 years might be a negative predictor for delayed cure in univariate analysis (p = 0.049).
Discussion

Assessment of persistent spasm after MVD
The exact reasons for surgical failure remain unclear. Therefore, the postoperative assessment of persistent HFS becomes a challenging decision regarding whether a repeat MVD should be performed. The percentage of delayed cure in this study (39 %) was relatively high and similar to that reported by Shin et al. (37.4 %) [11, 15, 17] . Zhong et al. stressed that a reoperation should be performed as soon as possible instead of expecting a delayed cure. They did not observe any delayed cure during the 1-year follow-up period for those with persistent spasm patients [22] . On the other hand, Sindou et al. strongly advised to wait 1 year after the initial surgery before making a decision for reoperation, because 13 % of their patients with excellent or good outcome had a delayed cure of 3 months to 1 year [18] . Kim et al. found the differences in clinical improvement between cured and unsatisfactory groups were not definite during the early follow-up period (post 3 days and post 1 month, p = 0.826 and p = 1.00) based on their statistically significant data [8] . Although some papers showed limited improvement with a high complication rate for preoperative MVD [1, 10] , recent surgical results of late reoperation did not show significant differences from those undergoing their initial MVDs [16, 20] . Our results showed that cumulative spasm-free rate at 3 months after operation was 97 %. Taking the recent improvement of repeat MVD outcome into consideration, the surgical outcome should be assessed at least 3 months after the initial operation.
Preoperative anticonvulsant therapy as a predictive factor for delayed cure
In previous reports, factors, such as intraoperative LSR, the pattern of neurovascular compression, the good clinical outcome at 3 months after the operation, and severity of the REZ indentation, have been proposed as prognostic factors for better outcomes [8, 9] . But, none was previously found to be significantly different between immediate cure and delayed cure groups [5, 6] . In this extensive investigation, multivariate analysis revealed a significant correlation between preoperative anticonvulsant therapy and delayed cure after MVD. In Japan, prescription of anticonvulsants to HFS patients by neu- rologist has been very popular prior to botulinum neurotoxin injection or MVD. Almost all enrolled patients in this study have tried AEDs at least once before the study. Therefore, selection bias for the anticonvulsant group would be minimum regardless of a retrospective study. Ephaptic transmission at the site of vascular compression and hyperexcitation of the facial nucleus might contribute in varying degrees to the HFS in each patient. Although medication for HFS is thought to be ineffective, some patients show obvious symptom improvement by taking AEDs. In these patients, hyperexcitation of the facial nucleus as a cause of HFS might be a larger contributor than those with no response to AEDs. It would be physiologically logical that the effect of surgical decompression takes over several months to decrease and normalize the firing threshold of hyperexcited facial nucleus.
Pathogenesis of HFS
There has been much debate regarding the clinical usefulness and the cause of the LSR whether it is originated from ephaptic transmission or hyperexcitation of the facial nucleus [13, 14] . Many papers have been published describing the prognostic value of the LSR resolution for predicting outcomes of MVD [4, 6, 9, 21] . On the other hand, some papers have indicated that the persistence of intraoperative LSR does not necessarily predict a poor long-term outcome of MVD [3, 19] . Many authors have agreed that the pathogenesis of HFS might not have a single cause. If the LSR was caused by ephaptic transmission at the site of vascular compression, it is easily understood that HFS would persist despite complete intraoperative LSR resolution in patients of whom hyperexcitation of the facial nucleus is the main contributor to the genesis of HFS. In our cohort, these phenomena were observed in eight patients.
Recently, Zhong et al. proposed a new pathogenesis of HFS based on their experimental studies using a HFS model in SD rats [22] . They concluded that the cause of HFS is an ectopic impulse emerging from the compressed facial nerve, which might be triggered by sympathetic endings in the offending arterial wall and delayed cure resulted from incomplete decompression.
A facial corticobulbar motor evoked potentials (FCoMEPs) reported by Fernando et al. showed a significant increment of the threshold for eliciting FCoMEP after MVD was completed. A simultaneous recording of LSR and FCoMEPs may add new insights for resolving the confusion surrounding the pathogenesis of HFS [2] .
Conclusions
In our cohort, 39 % of patients were included in the delayed cure group and the cumulative spasm-free rates at 1 week, 1 month, and 3 months after operation was 70, 88, and 97 %, respectively. According to multivariate analysis, preoperative anticonvulsant therapy was found to be the sole significant predictive factor for delayed cure. This result strongly suggested that the phenomenon of delayed cure was caused by hyperexcitation of the facial nucleus. Our results showed that the time when to conclude if the treatment has failed or not should be delayed for at least 3 months after the initial surgery, especially in patients with positive response to preoperative anticonvulsant therapy.
Comments
Marc Sindou, Lyon, France Not all patients get complete relief of their spasm before discharge after MVD procedure (37 % in our series). Decision of early reoperation is controversial. Our experience, like the one of the present authors, as well as of several other teams, is that secondary improvement, then cure, may be obtained after significant delay (as in two thirds of our patients who had still spasm after surgery). Delay can be from several months to one entire year, scarcely longer (only 3 in our overall series of 280 patients got (progressive) cure with a delay as long as 3 years). This experience leads us to advocate not to redo operation before term of the first year.
A number of teams use intraoperative facial EMG recordings to monitor lateral spread responses to facial branches' stimulation, for controlling efficacy of the decompression. Our experience, like (only a few) others, convinces us of the insufficient reliability of the method to be certain of the completeness of the decompression. Waiting, when there is estimation that the conflicting vessel(s) at facial REZ/brainstem has (have) been properly dislodged, is the only (wise) mean to manage with the patient's problem.
For the authors interested in the pathophysiology of primary HFS (among several: Aage Moller in particular), the main mechanism of this functional disease is hyperactivity of the facial nucleus, induced by the chronic, pulsatile, compression at the facial REZ/brainstem region. The fact that spasms may persist after an apparently effective decompression from the causal conflicting artery, and that cure needs a certain period of time to be achieved, is consistent with the underlying mechanism.
The merit of the present work is to provide some Bhelping^argument to incite waiting, especially in the patients who had responsiveness to anticonvulsant medications in their past history. We observed that in the patients with residual spasms after surgery, anticonvulsants could be (partially) effective, in spite of not having had significant effects prior their MVD.
